๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Alterations of the p16INK4A gene in human ovarian cancers

โœ Scribed by Tatsuya Kanuma; Jun-ichi Nishida; Tomonao Gima; J. Carl Barrett; Norio Wake


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
394 KB
Volume
18
Category
Article
ISSN
0899-1987

No coin nor oath required. For personal study only.

โœฆ Synopsis


The p16 INK4A gene, which encodes the cell-cycle regulatory protein cyclin-dependent kinase 4 inhibitor, is a putative tumor-suppressor gene. We examined p16 gene alterations in 30 primary ovarian cancers and 11 ovarian cancer cell lines. Five of the primary cancers (16.7%) had lost both p16 INK4A genes. In addition, four cancers (13.3%) contained five kinds of missense mutations and a one-base deletion. Three cell lines had homozygous deletions of p16 genes, and one cell line had multiple intragenic mutations. There was also suppressed transcription of the p16 gene in one cell line. Some point mutations occurred in the conserved ankylin consensus region. These observations suggest that p16 is a functional target for ovarian carcinogenesis and that p16 alterations occurred in the primary cancers.


๐Ÿ“œ SIMILAR VOLUMES


Infrequent alterations of the p16INK4A g
โœ Ryuichi Kita; Naoshi Nishida; Yoshihiro Fukuda; Hidemasa Azechi; Yoko Matsuoka; ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 499 KB ๐Ÿ‘ 1 views

We examined the genomic status of the p161NK4A (inhibitor of cyclin-dependent kinase 4 A) and cyclin-dependent kinase 4 (CDK4) genes in 62 human hepatocellular carcinomas (HCCs), 5 cholangiocellular carcinomas and 6 cell lines derived from human liver canceo. Although no samples showed the homozygou

Alterations of p16INK4A and p15INK4B gen
โœ Young Y. Lee; Shin H. Kang; Jin Y. Seo; Chul W. Jung; Kuhn U. Lee; Kuk J. Choe; ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 199 KB ๐Ÿ‘ 1 views

## Background: It has been suggested that cyclin-dependent kinase inhibitors (cdkis), including p16 and p15, are tumor suppressor genes. alterations of cdkis have been found in most types of cancer. however, little is known about the status of p16 and p15 genes, including methylation of the promote

Alteration of p16 and p15 genes in commo
โœ Masami Fujita; Takayuki Enomoto; Tomoko Haba; Ryuichi Nakashima; Makoto Sasaki; ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 244 KB ๐Ÿ‘ 1 views

We have examined the roles of 2 putative tumor-suppressor genes, the p16 and p15 inhibitor-of-cyclin-dependentkinase genes, in the most commonly occurring epithelial tumors of the human ovary. Expression of p16 mRNA, examined by RT-PCR, was significantly reduced in 15 of the 48 tumors. Aberrant expr

Alteration of pRb/p16/cdk4 regulation in
โœ M. Serena Benassi; Lara Molendini; Gabriella Gamberi; Paola Ragazzini; M. Rosa S ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 280 KB

Cell-cycle regulation depends on a fine balance between cyclin-cyclin-dependent kinase complexes and a family of kinase inhibitors that bind cyclin-cdk complexes and block their activity. To investigate the role of mechanisms regulating cell-cycle progression in human osteosarcomas (OS), pRb/p16/cdk

Mutational analysis of the p73 Gene in h
โœ Tomotane Shishikura; Shingo Ichimiya; Toshinori Ozaki; Yoshinori Nimura; Hajime ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 163 KB ๐Ÿ‘ 2 views

In primary breast cancer, mutations of the p53 tumor suppressor gene lead to loss of growth-suppressive properties and poor outcome. Recently, a p53-related gene, termed p73, has been cloned and its gene product possesses a function similar to p53. p73 has been mapped at chromosome 1p36.3, a region